Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint.

Salmela AL, Pouwels J, Varis A, Kukkonen AM, Toivonen P, Halonen PK, Perälä M, Kallioniemi O, Gorbsky GJ, Kallio MJ.

Carcinogenesis. 2009 Jun;30(6):1032-40. doi: 10.1093/carcin/bgp101. Epub 2009 Apr 24.

2.

Chromosomal passengers: the four-dimensional regulation of mitotic events.

Vagnarelli P, Earnshaw WC.

Chromosoma. 2004 Nov;113(5):211-22. Epub 2004 Sep 4. Review.

PMID:
15351889
3.

The survivin/Aurora B complex: its role in coordinating tension and attachment.

Lens SM, Medema RH.

Cell Cycle. 2003 Nov-Dec;2(6):507-10. Review.

PMID:
14504461
4.

Regulation of kinetochore-microtubule attachments by Aurora B kinase.

Liu D, Lampson MA.

Biochem Soc Trans. 2009 Oct;37(Pt 5):976-80. doi: 10.1042/BST0370976. Review.

PMID:
19754435
5.

Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins.

Carmena M, Ruchaud S, Earnshaw WC.

Curr Opin Cell Biol. 2009 Dec;21(6):796-805. doi: 10.1016/j.ceb.2009.09.008. Review.

6.

Targeting mitosis for anti-cancer therapy.

Sudakin V, Yen TJ.

BioDrugs. 2007;21(4):225-33. Review.

PMID:
17628120
7.

Mitosis as an anti-cancer drug target.

Salmela AL, Kallio MJ.

Chromosoma. 2013 Oct;122(5):431-49. doi: 10.1007/s00412-013-0419-8. Epub 2013 Jun 18. Review.

PMID:
23775312
8.

The role of clathrin in mitotic spindle organisation.

Royle SJ.

J Cell Sci. 2012 Jan 1;125(Pt 1):19-28. doi: 10.1242/jcs.094607. Review.

9.

The chromosomal passenger complex (CPC) as a key orchestrator of orderly mitotic exit and cytokinesis.

Kitagawa M, Lee SH.

Front Cell Dev Biol. 2015 Mar 5;3:14. doi: 10.3389/fcell.2015.00014. eCollection 2015. Review.

10.

Killing cells by targeting mitosis.

Manchado E, Guillamot M, Malumbres M.

Cell Death Differ. 2012 Mar;19(3):369-77. doi: 10.1038/cdd.2011.197. Epub 2012 Jan 6. Review.

11.

Role of prolonged mitotic checkpoint activation in the formation and treatment of cancer.

Dalton WB, Yang VW.

Future Oncol. 2009 Nov;5(9):1363-70. doi: 10.2217/fon.09.118. Review.

12.

The flavonoid fisetin as an anticancer agent targeting the growth signaling pathways.

Rengarajan T, Yaacob NS.

Eur J Pharmacol. 2016 Oct 15;789:8-16. doi: 10.1016/j.ejphar.2016.07.001. Epub 2016 Jul 2. Review.

PMID:
27377217
13.

Fisetin: a dietary antioxidant for health promotion.

Khan N, Syed DN, Ahmad N, Mukhtar H.

Antioxid Redox Signal. 2013 Jul 10;19(2):151-62. doi: 10.1089/ars.2012.4901. Epub 2012 Dec 18. Review.

14.

Exploring the molecular targets of dietary flavonoid fisetin in cancer.

Syed DN, Adhami VM, Khan N, Khan MI, Mukhtar H.

Semin Cancer Biol. 2016 Oct;40-41:130-140. doi: 10.1016/j.semcancer.2016.04.003. Epub 2016 May 6. Review.

PMID:
27163728
15.
16.

Fisetin and Its Role in Chronic Diseases.

Pal HC, Pearlman RL, Afaq F.

Adv Exp Med Biol. 2016;928:213-244. Review.

PMID:
27671819
17.

How fisetin reduces the impact of age and disease on CNS function.

Maher P.

Front Biosci (Schol Ed). 2015 Jun 1;7:58-82. Review.

Supplemental Content

Support Center